In conjunction with our previous observations concerning the roles of IFNγ and TLR7 in the regulation of SLE, our current findings reinforce the importance of potentially targeting these pathways for the treatment of SLE. The gene discussed is IFNG; the disease is systemic lupus erythematosus.